Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating Cardiovascular Adverse Events Related to Cancer Treatment: a Study of Extreme Toxicity Using Induced Pluripotent Stem Cells

NCT03199300 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT03199300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03199300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating Cardiovascular Adverse Events Related to Cancer Treatment: a Study of Extreme Toxicity Using Induced Pluripotent Stem Cells
Lead sponsor
University Medical Center Groningen
Phase
Observational
Overall status
Active, not recruiting
Start date
December 12, 2017
Completion date
January 31, 2027
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, treatment-related, cardiovascular morbidity, toxicity due to chemotherapy